Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer

Abstract

These findings suggest that machine learning models may identify patients with intermediate risk who could benefit from chemoradiation. These models predicted that approximately half of such patients have no added benefit from chemotherapy.